HIV阴性急性白血病患者化疗后并发耶氏肺孢子菌肺炎1例报告及文献复习

doi:10.13481/j.1671-587x.20190127

吉林大学学报(医学版) ›› 2019, Vol. 45 ›› Issue (01): 148-152.doi: 10.13481/j.1671-587x.20190127

• 临床医学 • 上一篇

HIV阴性急性白血病患者化疗后并发耶氏肺孢子菌肺炎1例报告及文献复习

曹文彬, 刘庆珍, 周卢坤, 郑晓辉, 陈书连, 张荣莉, 何祎, 冯四洲, 韩明哲, 杨栋林

中国医学科学院北京协和医学院血液学研究所血液病医院造血干细胞移植中心, 天津 300020

收稿日期:2018-08-29 发布日期:2019-01-28
通讯作者: 杨栋林,副主任医师(Tel:022-23909163,E-mail:yangdonglin@ihcams.ac.cn) E-mail:yangdonglin@ihcams.ac.cn
作者简介:曹文彬(1983-),女,山西省大同市人,主治医师,医学博士,主要从事血液病基础和临床方面的研究。

Pneumocystis jirovecii pneumonia in non-HIV-infected patients with acute leukemia after chemotherapy: A case report and literature review

CAO Wenbin, LIU Qingzhen, ZHOU Lukun, ZHENG Xiaohui, CHEN Shulian, ZHANG Rongli, HE Yi, FENG Sizhou, HAN Mingzhe, YANG Donglin

Hematopoietic Stem Cell Transplantation Center, Blood Disease Hospital, Institute of Hematology, Peking Union Medical College, Chinese Academy of Medical Sciences, Tianjin 300020, China

Received:2018-08-29 Published:2019-01-28
Contact: 国家自然科学基金资助课题（81670171）；中国医学科学院医学与健康科技创新工程项目资助课题（2016-I2M-3-023）；中华医学会临床医学科研专项资金资助课题（16010130629） E-mail:yangdonglin@ihcams.ac.cn

摘要/Abstract

摘要： 目的：探讨人类免疫缺陷病毒（HIV）阴性血液病患者并发耶氏肺孢子菌肺炎（PCP）的临床特点，分析其高危因素、治疗方法、预后和预防措施。方法：1例18岁女性急性髓系白血病患者，在巩固化疗血象恢复正常后出现胸闷、憋气，血氧饱和度下降，胸部CT提示双肺出现弥漫磨玻璃影，经抗细菌治疗5d无效，出现干咳，血氧饱和度进行性下降至75%，复查胸部CT示双肺磨玻璃影范围增大，考虑为PCP，予复方磺胺甲恶唑（TMP/SMZ）1g、每6h1次联合卡泊芬净治疗。结果：治疗2d后患者症状无改善，转至ICU，经支气管肺泡灌洗确诊PCP，予TMP/SMZ 2g、每8h 1次联合卡泊芬净抗PCP，同时予双水平气道正压（Bipap）通气，5d后症状改善，停呼吸机辅助呼吸，继续治疗5d后好转出院，院外单用TMP/SMZ 2g、每8h 1次，共口服36d痊愈停药。结论：HIV阴性急性白血病化疗患者要注意PCP的预防。未行预防的血液病患者，一旦在非粒细胞缺乏期出现疑似PCP的临床表现，要考虑PCP诊断。及早行经验性抗PCP治疗，一旦发生呼吸衰竭及时转入ICU是减少死亡和改善预后的关键。

关键词: 急性白血病, 人类免疫缺陷病毒, 血液病, 耶氏肺孢子菌肺炎, 化学疗法

Abstract: Objective: To discuss the clinical characteristicsof the Pneumocystis jirovecii pneumonia (PCP) in the non-HIV-infected blood disease patients,and to analyze its risk factors, treatment methods, prognosis and prevention measures.Methods: A female patient aged 18 years old was confirmed as acute myeloid leukemia (AML),and experienced dyspnea, chest congestion and hypoxaemia during the recovery period of hemogram after chemotherapy. The chest CT showed the bilateral lung diffuse ground glass density images. The patient had a dry cough and the oxygen saturation was gradually decreased to 75% 5 d after antibacteriological treatment. A repeat chest CT showed enlarged diffuse ground glass density images on both lungs. Considering about the possibility of PCP,the patient received oral trimethoprim/sulfamethoxazole(TMP/SMX) 1 g, once every 6 h, in combination with caspofungin.Results: Two days later,the symptoms of the patients were not improved. The patient was transferred to ICU and was diagnosed PCP by bronchoalveolar lavage. The patient was switched to oral TMP/SMX 2g, once every 8 h, in combination with caspofungin. Meanwhile,the patient received bi-level positive airway pressure ventilation (Bipap) for the increased work of breathing. Five days later,the symptoms of the patients were improved and the Bipap was stopped. The patient got better and discharged 5 d later. The patient continuely received oral TMP/SMX 2 g, once every 8 h for 36 d.Conclusion: Prevention of PCP should be focused, in the non-HIV-infected blood disease patients receiving chemotherapy. Diagnosis of PCP should be considered in these patients without prevention who once have suspected clinical manifestation of PCP in non-granulocytic phase. Early empirical treatment of PCP and ICU management in the non-HIV-infected blood disease patients with acute respiratory failure are the keys to reduce death and improve the prognosis of PCP.

Key words: acute leukemia, human immunodefieiency virus, haematology, Pneumocystis jirovecii pneumonia, chemotherapy

中图分类号:

R733.71

曹文彬, 刘庆珍, 周卢坤, 郑晓辉, 陈书连, 张荣莉, 何祎, 冯四洲, 韩明哲, 杨栋林. HIV阴性急性白血病患者化疗后并发耶氏肺孢子菌肺炎1例报告及文献复习[J]. 吉林大学学报(医学版), 2019, 45(01): 148-152.

CAO Wenbin, LIU Qingzhen, ZHOU Lukun, ZHENG Xiaohui, CHEN Shulian, ZHANG Rongli, HE Yi, FENG Sizhou, HAN Mingzhe, YANG Donglin. Pneumocystis jirovecii pneumonia in non-HIV-infected patients with acute leukemia after chemotherapy: A case report and literature review[J]. Journal of Jilin University(Medicine Edition), 2019, 45(01): 148-152.

参考文献

[1] LIU Y, SU L, JIANG SJ,et al. Risk factors for mortality from Pneumocystis carinii pneumonia (PCP) in non-HIV patients:a meta-analysis[J]. Oncotarget,2017,8(35):59729-59739.
[2] CORDONNIER C,CESARO S,MASCHMEYER G,et al. Pneumocystis jirovecii pneumonia:still a concern in patients with haematological malignancies and stem cell transplant recipients[J].J Antimicrob Chemother,2016,71(9):2379-2385.
[3] TORRES H A,CHEMALY R F,STOREY R, et al. Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients[J]. Eur J Clin Microbiol Infect Dis, 2006,25(6):382-388.
[4] MCKINNELL J A,CANNELLA A P,KUNZ D F,et al. Pneumocystis pneumonia in hospitalized patients:a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons[J]. Transpl Infect Dis,2012,14(5):510-518.
[5] ROBERT-GANGNEUX F,BELAZ S,REVEST M, et al. Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR:a 4-year prospective study[J]. J Clin Microbiol,2014,52(9):3370-3376.
[6] LAHMER T,DA COSTA C P,HELD J,et al. Usefulness of 1,3 beta-d-glucan detection in non-HIV immunocompromised mechanical ventilated critically Ill patients with ARDS and suspected Pneumocystis jirovecii pneumonia[J]. Mycopathologia,2017,182(7):701-708.
[7] ROBLOT F,LE MOAL G,KAUFFMANN-LACROIX C, et al. Pneumocystis jirovecii pneumonia in HIV-negative patients:a prospective study with focus on immunosuppressive drugs and markers of immune impairment[J]. Scand J Infect Dis,2014,46(3):210-214.
[8] MESSIAEN P E,CUYX S,DEJAGERE T,et al. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients:A systematic review[J]. Transpl Infect Dis,2017,19(2):e12651.
[9] BIENVENU A L,TRAORE K,PLEKHANOVA I, et al. Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients[J]. Int J Infect Dis, 2016, 46:11-17.
[10] LI MC, LEE NY, LEE CC, et al.Pneumocystis jiroveci pneumonia in immunocompromised patients:delayed diagnosis and poor outcomes in non-HIV-infected individuals[J]. J Microbiol Immunol Infect,2014,47(1):42-47.
[11] MASCHMEYER G, HELWEY-LARSEN J,PAGANO L, et al. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients[J]. J Antimicrob Chemother,2016,71(9):2405-2413.
[12] AMADO-RODRÍGUEZ L, BERNAL T, López-Alonso I, et al. Impact of initial ventilatory strategy in hematological patients with acute respiratory failure:A systematic review and Meta-analysis[J]. Crit Care Med, 2016,44(7):1406-1413.
[13] LEMIALE V,DEBRUMETZ A,DELANNOY A, et al. Adjunctive steroid in HIV-negative patients with severe pneumocystis pneumonia[J]. Respir Res, 2013, 14:87.
[14] GREEN H,PAUL M,VIDAL L, et al. Prophylaxis of pneumocystis pneumonia in immunocompromised non-HIV-infected patients:systematic review and meta-analysis of randomized controlled trials[J]. Mayo Clin Proc, 2007, 82(9):1052-1059.
[15] MAERTENS J,CESARO S,MASCHMEYER G, et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients[J]. J Antimicrob Chemother,2016, 71(9):2397-2404.

HIV阴性急性白血病患者化疗后并发耶氏肺孢子菌肺炎1例报告及文献复习

Pneumocystis jirovecii pneumonia in non-HIV-infected patients with acute leukemia after chemotherapy: A case report and literature review

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

Metrics

本文评价

推荐阅读 0

[1]	马鸿云, 庄新明, 许维国, 刘一. 载阿霉素和顺铂的透明质酸纳米粒子对小鼠移植性乳腺癌的抑制作用[J]. 吉林大学学报(医学版), 2018, 44(02): 243-248.
[2]	司延芳, 莫冉冉, 李慧婷, 宋鹏, 李明娴. 艾滋病伴肾上腺皮质功能减退症1例报告并文献复习[J]. 吉林大学学报(医学版), 2017, 43(05): 1030-1033.
[3]	苏军燕, 李迎今, 徐长妍. 急性白血病患儿白血病干细胞表面CD96和CD71的表达对其疗效和预后的影响[J]. 吉林大学学报(医学版), 2017, 43(04): 776-781.
[4]	糟航, 王旭, 李薇. CDA基因单核苷酸多态性对中晚期非小细胞肺癌接受吉西他滨化疗患者预后的影响[J]. 吉林大学学报(医学版), 2016, 42(02): 316-320.
[5]	王昆鹏, 赵文清, 王维兴, 呼铁民, 康进生, 孙鑫, 鞠智卿. 动脉灌注化疗对大鼠脑胶质瘤的治疗作用及其机制[J]. 吉林大学学报(医学版), 2015, 41(02): 327-332.
[6]	曹新梅，张岱权，王栩，夏纪毅，黄黎，高燕. C-erbB-2 shRNA对小鼠肺腺癌细胞化疗敏感性的影响及其机制[J]. 吉林大学学报(医学版), 2014, 40(04): 777-781.
[7]	陈鹏，王秀丽，李景贺，贾娇媛，卢爱萍，姜玉珍. DcR3 mRNA在白血病细胞中的表达及意义[J]. J4, 2007, 33(6): 1050-1053.